{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:08:41Z","timestamp":1790564921931,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012335","name":"Medical and Life Sciences Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012335","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ebiom.2020.103083","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T18:03:21Z","timestamp":1604599401000},"page":"103083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis\u2014A multicentre study"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-7864","authenticated-orcid":false,"given":"Ayman S.","family":"Bannaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Voigtl\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Book","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Melgarejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Latosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pejchinovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Staessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh P.","family":"Arasaradnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.103083_bib0001","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2020.103083_bib0002","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2020.103083_bib0003","first-page":"9026","article-title":"Role of liver biopsy in nonalcoholic fatty liver disease","volume":"20","author":"Nalbantoglu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ebiom.2020.103083_bib0004","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.03.008","article-title":"Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease","volume":"150","author":"Bedossa","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2020.103083_bib0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2020.103083_bib0006","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-0035-1562948","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease","volume":"35","author":"Castera","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ebiom.2020.103083_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2014.04.039","article-title":"FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice","volume":"13","author":"Tapper","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2020.103083_bib0008","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s10620-013-2705-y","article-title":"Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK","volume":"58","author":"Canavan","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ebiom.2020.103083_bib0009","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2020.103083_bib0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cld.2012.05.001","article-title":"Can NASH be diagnosed, graded, and staged noninvasively?","volume":"16","author":"Grandison","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ebiom.2020.103083_bib0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.28776","article-title":"Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease","volume":"65","author":"Ajmera","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2020.103083_bib0012","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/pr1002593","article-title":"Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease","volume":"9","author":"Barr","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ebiom.2020.103083_bib0013","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1155\/2014\/757929","article-title":"Biomarkers in nonalcoholic fatty liver disease","volume":"28","author":"Neuman","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2020.103083_bib0014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2020.103083_bib0015","doi-asserted-by":"crossref","first-page":"16915","DOI":"10.1038\/s41598-017-17083-w","article-title":"Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?","volume":"7","author":"Magalh\u00e3es","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2020.103083_bib0016","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ejhf.544","article-title":"Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates","volume":"18","author":"Farmakis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ebiom.2020.103083_bib0017","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jchromb.2008.10.048","article-title":"Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment","volume":"877","author":"Dakna","year":"2009","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.ebiom.2020.103083_bib0018","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/elps.201900091","article-title":"Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: the past, the present, and the future","volume":"40","author":"Latosinska","year":"2019","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ebiom.2020.103083_bib0019","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clinbiochem.2012.09.025","article-title":"Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience","volume":"46","author":"Mischak","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ebiom.2020.103083_bib0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/pr800401m","article-title":"Quantitative urinary proteome analysis for biomarker evaluation in kidney disease","volume":"8","author":"Jantos-Siwy","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ebiom.2020.103083_bib0021","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/elps.201300327","article-title":"Comparison of CE-MS\/MS and LC-MS\/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine","volume":"35","author":"Klein","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ebiom.2020.103083_bib0022","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/elps.200500827","article-title":"Biomarker discovery by CE-MS enables sequence analysis via MS\/MS with platform-independent separation","volume":"27","author":"Z\u00fcrbig","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ebiom.2020.103083_bib0023","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/pmic.201200493","article-title":"Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation","volume":"13","author":"Klein","year":"2013","journal-title":"Proteomics"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2020.103083_bib0024","doi-asserted-by":"crossref","first-page":"D546","DOI":"10.1093\/nar\/gkl813","article-title":"CutDB: a proteolytic event database","volume":"35","author":"Igarashi","year":"2007","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.ebiom.2020.103083_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12929-019-0599-5","article-title":"Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma","volume":"27","author":"Voigtl\u00e4nder","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ebiom.2020.103083_bib0026","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.103083_bib0027","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41467-018-03311-y","article-title":"Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2020.103083_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.ebiom.2020.103083_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"issue":"Suppl(1)","key":"10.1016\/j.ebiom.2020.103083_bib0030","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jhep.2004.12.008","article-title":"Fibrosis in chronic liver diseases: diagnosis and management","volume":"42","author":"Pinzani","year":"2005","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103083_bib0031","doi-asserted-by":"crossref","first-page":"e62837","DOI":"10.1371\/journal.pone.0062837","article-title":"CKD273, a new proteomics classifier assessing CKD and its prognosis","volume":"8","author":"Argil\u00e9s","year":"2013","journal-title":"PLoS ONE"},{"issue":"18","key":"10.1016\/j.ebiom.2020.103083_bib0032","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/eurheartj\/ehs185","article-title":"Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction","volume":"33","author":"Kuznetsova","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ebiom.2020.103083_bib0033","doi-asserted-by":"crossref","first-page":"8","DOI":"10.18433\/J3F61F","article-title":"Non-alcoholic steatohepatitis: clinical and translational research","volume":"19","author":"Neuman","year":"2016","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.ebiom.2020.103083_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201800111","article-title":"Urinary glycopeptide analysis for the investigation of novel biomarkers","volume":"13","author":"Belczacka","year":"2019","journal-title":"Proteom Clin Appl"},{"key":"10.1016\/j.ebiom.2020.103083_bib0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2020.103083_bib0036","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2012-302047","article-title":"Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders","volume":"62","author":"Metzger","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2020.103083_bib0037","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/2050640616687836","article-title":"A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin","volume":"5","author":"Voigtl\u00e4nder","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.ebiom.2020.103083_bib0038","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.1074\/jbc.M111.314179","article-title":"Biochemical characterization and Nterminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities","volume":"287","author":"Starr","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2020.103083_bib0039","doi-asserted-by":"crossref","unstructured":"Ferreras M., Felbor U., Lenhard T., Olsen B.R., Delaiss\u00e9 J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett; 486: 247\u201351.","DOI":"10.1016\/S0014-5793(00)02249-3"},{"key":"10.1016\/j.ebiom.2020.103083_bib0040","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2020.103083_bib0041","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/ctg.2017.25","article-title":"Cathepsin L and B as potential markers for liver fibrosis: insights from patients and experimental models","volume":"8","author":"Manchanda","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103083_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700163","article-title":"Comparison of urine and plasma peptidome indicates selectivity in renal peptide handling","volume":"12","author":"Magalh\u00e3es","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.ebiom.2020.103083_bib0043","first-page":"940","article-title":"Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease","volume":"23","author":"Arthur","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ebiom.2020.103083_bib0044","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/1354750X.2019.1652347","article-title":"Urinary cell cycle arrest biomarker [TIMP-2]\u2022[IGFBP7] in patients with hepatorenal syndrome","volume":"24","author":"Zhang","year":"2019","journal-title":"Biomarkers"},{"key":"10.1016\/j.ebiom.2020.103083_bib0045","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.amjcard.2017.03.036","article-title":"Usefulness of collagen carboxy-terminal propeptide and telopeptide to predict disturbances of long-term mortality in patients \u226560 years with heart failure and reduced ejection fraction","volume":"119","author":"L\u00f6fsj\u00f6g\u00e5rd","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ebiom.2020.103083_bib0046","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhepr.2019.06.004","article-title":"Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease","volume":"1","author":"Boyle","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ebiom.2020.103083_bib0047","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/leu.2013.210","article-title":"Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"28","author":"Weissinger","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ebiom.2020.103083_bib0048","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"Good","year":"2010","journal-title":"Mol Cell Proteom"},{"key":"10.1016\/j.ebiom.2020.103083_bib0049","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.2337\/db12-0348","article-title":"Urinary proteomics for early diagnosis in diabetic nephropathy","volume":"61","author":"Zurbig","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2020.103083_bib0050","doi-asserted-by":"crossref","first-page":"198ra06","DOI":"10.1126\/scitranslmed.3005807","article-title":"Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV)","volume":"5","author":"Klein","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2020.103083_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30026-7","article-title":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomized placebo-controlled trial","author":"Tofte","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642030459X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642030459X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:01:22Z","timestamp":1762455682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642030459X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":51,"alternative-id":["S235239642030459X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103083","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis\u2014A multicentre study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103083"}}